News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Geron Corporation (GERN) Receives Milestone Payment From Exeter Life Sciences, Inc.


4/15/2008 9:01:52 AM

MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) announced that is has received a milestone payment of $1.5 million from Exeter Life Sciences, Inc. as a result of the final Risk Assessment released by the U.S. Food and Drug Administration addressing food products made from cloned animals or their progeny. The Risk Assessment, available at http://www.fda.gov/cvm/CloneRiskAssessment_Final.htm, concluded that consumption of such food products poses no greater risk than consumption of food products from animals produced by conventional breeding methods.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES